From: Host cell protein platform assay development for therapeutic mAb bioprocessing using mammalian cells
 | Null cell line CPP (2L scale) | Null cell line CPP-20% (2L scale) |
---|---|---|
% of spot coverage in the supernatant | 71 | 72 |
% of spot coverage in the supernatant | 65 | 64 |